Key result
Almost 50% of cardiological patients with an aggravated oncoanamnesis had a state of thrombotic readiness, with thrombodynamic indices being higher in active oncopathology versus remission.
Why the study?
Diagnosing hemocoagulation complications in patients with comorbid cardiovascular disease and oncopathology remains complex and an urgent clinical problem.
Does an active oncological process increase thrombotic readiness as measured by the thrombodynamics test in patients with cardiovascular disease compared to those in remission?
Observational (n=100)
Does an active oncological process increase thrombotic readiness as measured by the thrombodynamics test in patients with cardiovascular disease compared to those in remission?
The thrombodynamics test can identify states of thrombotic readiness in cardio-oncology patients that are missed by standard coagulograms, particularly in those with active cancer.
Thrombodynamics may identify thrombotic readiness missed by standard coagulograms in cardio-oncology patients; leaves open its diagnostic utility pending prospective validation.
Today cardiovascular diseases and oncopathology are leading causes in the structure of mortality worldwide. The complexity of diagnostics of haemocoagulation complications in this comorbid pathology remains an urgent problem at present. The aim of our study was to investigate the mechanisms of thrombotic readiness state formation using the thrombodynamics test on the example of patients with cardiovascular diseases (CHD, arterial hypertension) and aggravated oncoanamnesis depending on the activity of oncoprocess. The study was conducted in 100 patients aged 37 – 86 years: 60 patients with active oncoprocess (group 1) and 40 patients with oncoprocess in remission (group 2). Clinical, anamnestic and laboratory data were studied using a statistical analysis. The main attention was paid to the thrombodynamics test indicators (both velocity and structural). It was found that the most informative indicators of the haemostasis system state estimation in patients with cardiovascular pathology and aggravated oncoanamnesis depending on the oncoprocess activity are thrombodynamic indices both velocity and structural. Almost half of cardiological patients with an aggravated oncoanamnesis had a state of thrombotic readiness irrespective of the activity of the oncological process. These indices were higher in active oncopathology than in oncopathology in remission. At the same time no differences in the data of standard coagulogram in both groups could be revealed. Application of thrombodynamics test in cardiological patients with oncoanamnesis allows to reveal the states of thrombotic readiness and to establish the degree of influence of oncoprocess activity on the formation of this state, which demonstrates fundamentally new aspects of diagnostics of procoagulant states in patients of this profile.
No takes yet. Share an insight, caveat, or question.
Ramazanova et al. (2023) conducted an observational in Cardiovascular diseases and aggravated oncoanamnesis (n=100). Active oncological process vs. Oncological process in remission was evaluated on Thrombotic readiness state (thrombodynamics test indicators). Almost 50% of cardiological patients with an aggravated oncoanamnesis had a state of thrombotic readiness, with thrombodynamic indices being higher in active oncopathology versus remission.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: